Transcatheter Aortic Valve Replacement (TAVR) is the latest technique in the interventional cardiology field. Moreover, it refers to transcatheter aortic valve implantation/replacement, which is a procedure where the aortic valve is replaced with a biological valve without open-heart surgery. Also, it increases the survival of the patients.

Presently, the TAVI procedure is used in patients who are at high risk for open heart surgery. It is a biological valve and has shown similar results as open heart surgery in various trials. For further details, please use this contact form.

Many valves are in the pipeline of development. Two valves that are widely used are the Sapien valve and Corevalve. The Sapien valve is a balloon-expandable valve made of the bovine pericardium and sewn inside a metallic stent. Corevalve is a self-expanding valve made of porcine pericardium sewn inside a nitinol frame.

90% of the valves are inserted via the femoral(groin) approach. These are authorized early ambulation and discharge. The other techniques are trans aortic, trans axillary, and trans apical.

It clips the leaky segment of the valve and approximates them when the valve closes, thereby treating the leak. Furthermore, contact us.

It is a safe procedure when done at a center of excellence and by an expert. The procedure is done from the femoral(groin) vein. The chances of bleeding are minimal.

Successful implantation of MitraClip reduces the leak. It improves the symptoms dramatically and decreases recurrent hospitalization.

MitraClip is widely used in Europe for functional mitral regurgitation. It improves patient symptoms and heart function.